Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00887614 · ClinicalTrials.gov registry record · NA
Mindfulness, Emotional Well-being, and Sleep Quality
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 372
- Enrollment target
NCT00887614: Completed NA study, sponsored by Duke University.
NCT00887614 is a NA study that has completed, run by Duke University. The registered enrollment target is 372 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00887614, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 372 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether participating in a Mindfulness-Based Stress Reduction (MBSR) program increases mindful attention and awareness, and whether anticipated changes in mindfulness relate to improved emotional well-being, sleep quality, physical symptoms of stress, sense of spirituality, and quality of life following MBSR.
Primary Outcome
Attention to and awareness of thoughts and feelings.
Interventions
- BEHAVIORAL Mindfulness-Based Stress Reduction (MBSR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 372 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-06 |
| Phase | NA |
What the finished NCT00887614 record still lists
NCT00887614 is an interventional study that assigns participants to a tested intervention. The registered 372 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Mindfulness-Based Stress Reduction (MBSR) is the first listed.
NCT00887614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00887614 about?
NCT00887614 is a clinical study titled "Mindfulness, Emotional Well-being, and Sleep Quality". The purpose of this study is to determine whether participating in a Mindfulness-Based Stress Reduction (MBSR) program increases mindful attention and awareness, and whether anticipated changes in mindfulness relate to improved emotional well-being, sleep quality, physical symptoms of stress, sense ...
What is the current status of trial NCT00887614?
This trial is currently completed. It is a NA study. The enrollment target is 372 participants. The study started on 2009-07. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00887614?
The interventions under investigation include: Mindfulness-Based Stress Reduction (MBSR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00887614?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00887614's enrollment target sits among peer trials
372 280th of 2000 higher than 1,720 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- NCT05318105 · 372 participants · NA
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
- NCT06797635 · 372 participants · Phase 2
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia